Acasunlimab, KEYTRUDA 25 mg/mL concentrate for solution for infusion
GCT1046-07
Phase 2 small_molecule active
Quick answer
Acasunlimab, KEYTRUDA 25 mg/mL concentrate for solution for infusion for Cutaneous Melanoma, Relapsed/Refractory, Locally Advanced Unresectable Melanoma (Stage IIIB, IIIC, or IIID), Metastatic Cutaneous Melanoma (Stage IV) is a Phase 2 program (small_molecule) at Genmab A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Genmab A/S
- Indication
- Cutaneous Melanoma, Relapsed/Refractory, Locally Advanced Unresectable Melanoma (Stage IIIB, IIIC, or IIID), Metastatic Cutaneous Melanoma (Stage IV)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active